Presentation is loading. Please wait.

Presentation is loading. Please wait.

Agency for Healthcare Research and Quality

Similar presentations


Presentation on theme: "Agency for Healthcare Research and Quality"— Presentation transcript:

1 Agency for Healthcare Research and Quality
Building a Bridge Over the Quality Chasm: The Role of AHRQ and the UT System Carolyn M. Clancy, MD Director Agency for Healthcare Research and Quality UT Clinical Safety and Effectiveness Inaugural Conference Austin, TX – October 15, 2009

2 The Fundamental Problem
“The fundamental problem with the quality of American medicine is that we’ve failed to view delivery of health care as a science. … That’s a mistake, a huge mistake.” Peter Pronovost, MD

3 Challenges Concerns about health spending – about $2.3 trillion per year in the U.S. and growing Pervasive problems with the quality of care that people receive Large variations and inequities in clinical care Uncertainty about best practices involving treatments and technologies Translating scientific advances into actual clinical practice and usable information both for clinicians and patients

4 Building a Bridge at the Quality Chasm
AHRQ’s Role The Quality Chasm Getting There from Here Q&A

5 AHRQ’s Mission Improve the quality, safety, efficiency and effectiveness of health care for all Americans

6 HHS Organizational Focus
NIH Biomedical research to prevent, diagnose and treat diseases CDC Population health and the role of community-based interventions to improve health AHRQ Long-term and system-wide improvement of health care quality and effectiveness

7 AHRQ Priorities Patient Safety Ambulatory Patient Safety
Health IT Patient Safety Organizations New Patient Safety Grants Ambulatory Patient Safety Effective Health Care Program Comparative Effectiveness Reviews Comparative Effectiveness Research Clear Findings for Multiple Audiences Safety & Quality Measures, Drug Management and Patient-Centered Care Patient Safety Improvement Corps Medical Expenditure Panel Surveys Other Research & Dissemination Activities Visit-Level Information on Medical Expenditures Annual Quality & Disparities Reports Quality & Cost-Effectiveness, e.g. Prevention and Pharmaceutical Outcomes U.S. Preventive Services Task Force MRSA/HAIs

8 AHRQ Roles and Resources
Health IT Research Funding Support advances that improve safety and quality Continue work in hospital settings Step up use of HIT to improve ambulatory care Develop Evidence Base for Best Practices Patient-centered care Medication management Integration of decision support tools Enabling quality measurement Promote Collaboration and Dissemination Support efforts of other federal agencies (e.g., CMS, HRSA) Build on public and private partnerships Use web tools to share knowledge and expertise

9 Plus: significant ARRA funding (more on that later)
AHRQ FY 2009 Funding $372 million $37 million more than FY 2008 $46 million more than the president’s request FY 2009 appropriation includes: $50 million for comparative effectiveness research, $20 million more than FY 2008 $49 million for patient safety activities $45 million for health IT Plus: significant ARRA funding (more on that later)

10 Building a Bridge at the Quality Chasm
AHRQ’s Role The Quality Chasm Getting There from Here Q&A

11 The Quality Chasm: The STEEEP Challenge
In 1999, in To Err is Human, Institute of Medicine estimated that 44,000 to 98,000 patients die each year in the United States as a result of medical error In 2001, IOM observed that a “quality chasm” exists between the care that should be provided and care that actually is provided IOM defined quality care as care that is safe, timely, effective, efficient, equitable, and patient centered

12 2008 Healthcare Quality Report
Key Themes Health care quality is suboptimal and improves at a slow pace (1.8% annually for core measures; 1.4% for all measures) Reporting of hospital quality is spurring improvement, but patient safety is lagging Health care quality measurement is evolving but much work remains

13 2008 Healthcare Disparities Report
Key Themes: Disparities persist in health care quality and access Magnitude and pattern of disparities are different within subpopulations Some disparities exist across multiple priority populations

14 Texas: Dashboard on Overall Health Care Quality vs. All States
Average Weak Strong Very Weak Very Strong Performance Meter: All Measures = Most Recent Year = Baseline Year 2008 National Healthcare Quality Report, State Snapshots

15 Texas Snapshot Measure Performance % of hospital patients age 65 and over with pneumonia who received pneumococcal screening or vaccination Better than average % of hospital patients with heart attack who received aspirin within 24 hours of admission Average % of adult surgery patients who received appropriate timing of antibiotics Worse than average 2008 National Healthcare Quality Report, State Snapshots

16 Tools to Address the Chasm
Health IT (efficiency, timeliness) Comparative effectiveness research (safety, effectiveness) Direct engagement with consumers (equity, patient-centeredness)

17 AHRQ Health IT Research Funding
AHRQ Health IT Investment: $260 Million Long-term agency priority AHRQ has invested more than $260 million in contracts and grants More than 150 communities, hospitals, providers, and health care systems in 48 states

18 AHRQ Health IT Initiative
State and regional demonstrations Health IT grants Privacy and security solutions for interoperable health information exchange ASQ Initiative E-prescribing pilots CDS demonstrations Technical assistance for Medicaid and CHIP agencies

19 AHRQ National Resource Center for Health IT
Established in 2004 Central national source of information and assistance for advancing health IT goals Maintains operation of the AHRQ health IT Web site Direct technical assistance to AHRQ grantees Repository for lessons learned from AHRQ’s health IT initiative

20 Health IT EPC Report First synthesis of existing evidence on factors influencing the usefulness, usability, barriers and drivers to use, and effectiveness of consumer applications The top factor associated with use by patients was the perception of a health benefit Patients prefer systems tailored to them that incorporate familiar devices

21 AHRQ National Resource Center for Health IT Web Site
Features AHRQ’s portfolio of health IT projects Funding opportunities News releases Emerging lessons and best practices Meetings and events

22 Ambulatory Safety and Quality (ASQ) Program
Purpose: Improve safety and quality of ambulatory health care in the U.S. More than 60 grants Sample types of health IT used in projects: PHRs Clinical/medication reminders Clinical decision support Telehealth Human/machine interface

23 ASQ Grants: Texas Using Electronic Records To Detect and Learn From Ambulatory Diagnostic Errors – University of Texas Health Science Center at Houston Type of Health IT: Operational decision support (quality of care) Duration of Project: 9/30/2007 – 9/29/2009 Using Information Technology To Provide Measurement-Based Care for Chronic Illness – Texas Southwest Medical Center at Dallas Type of Health IT: CDS (provider-focused) Duration of project: 9/3-/2007 – 9/29/2010

24 What is Comparative Effectiveness Research?

25 Essential Questions Posed by Comparative Effectiveness
The Effective Health Care Program engages in comparative effectiveness research. We’ve all heard a lot about comparative effectiveness research recently, some of it true, some of it not so much. So I think it’s important to step back and discuss what this endeavor is all about. You’ll recall that one of the six aims of a quality health care system as designated by the Institute of Medicine is that health care should be effective. “Effectiveness” is often difficult to gauge. What do we mean by that? How do we measure that? It would make everyone’s life so much easier if, when you had one patient, you had one treatment. Apply the one treatment, and the patient gets better. Unfortunately that’s not how modern medicine works. Because every patient is different, and every set of circumstances is different, there are usually multiple options facing patients and clinicians. Even in cancer, where our courses of treatment often are pretty straightforward, there are gray areas—lots of them. For instance, and I’ll have more to say about this in a moment, when you have a woman in her mid-40s with a family history of breast cancer, should we administer certain medications as a means of prophylaxis? If so, should we use tamoxifen, which is the most widely accepted? Or should we use other drugs that sometimes are used?

26 Essential Questions Posed by Comparative Effectiveness
So the essential nature of comparative effectiveness research is that it hits at the “effectiveness” aim that the IOM calls for. But it also gets at another critical IOM quality aim: patient-centeredness. Because every patient is different, not only in his or her diseases but also in his or her desires as a patient and as a human being. Is this treatment right? Is this treatment right for me?

27 AHRQ Comparative Effectiveness Research
http//:effectivehealthcare.ahrq.gov

28 Effective Health Care Program
Evidence synthesis (EPC program) Systematically reviewing, synthesizing, comparing existing evidence on treatment effectiveness Identifying relevant knowledge gaps Evidence generation (DEcIDE, CERTs) Development of new scientific knowledge to address knowledge gaps. Accelerate practical studies Evidence communication/translation (Eisenberg Center) Translate evidence into improvements Communication of scientific information in plain language to policymakers, patients, and providers

29 AHRQ Priority Conditions
Arthritis and non-traumatic joint disorders Cancer Cardiovascular disease, including stroke and hypertension Dementia, including Alzheimer Disease Depression and other mental health disorders Developmental delays, attention-deficit hyperactivity disorder and autism Diabetes Mellitus Functional limitations and disability Infectious diseases including HIV/AIDS Obesity Peptic ulcer disease and dyspepsia Pregnancy including pre-term birth Pulmonary disease/Asthma Substance abuse

30 Comparative Effectiveness and the Recovery Act
The American Recovery and Reinvestment Act of 2009 includes $1.1 billion for comparative effectiveness research: AHRQ: $300 million NIH: $400 million (appropriated to AHRQ and transferred to NIH) Office of the Secretary: $400 million (allocated at the Secretary’s discretion) Funding for health IT, prevention and other areas have implications for the Agency

31 Translating the Science into Real-World Applications
Examples of Recovery Act-funded Evidence Generation projects: Clinical and Health Outcomes Initiative in Comparative Effectiveness (CHOICE): First coordinated national effort to establish a series of pragmatic clinical comparative effectiveness studies ($100M) Request for Registries: Up to five awards for the creation or enhancement of national patient registries, with a primary focus on the 14 priority conditions ($48M) DEcIDE Consortium Support: Expansion of multi-center research system and funding for distributed data network models that use clinically rich data from electronic health records ($24M)

32 The Bottom Line “Patients’ ratings of hospital care are of interest because they are, in many ways, “the bottom line.”’ New England Journal of Medicine Patients’ Perspectives of Care in the United States New England Journal of Medicine 359;18 October 30, 2008

33 AHRQ Patient Engagement Campaigns
Primary Campaign Spanish-Language Campaign Men’s Preventive Health Campaign PSA by Fran Drescher

34 Plain Language Guides in English & Spanish

35 Hispanic Elderly Initiative
HHS pilot initiative aimed at improving the health and quality of life for Hispanic elders Eight metropolitan communities selected to participate in the pilot: Chicago, Houston, Los Angeles, McAllen, Miami, New York, San Antonio, and San Diego Medicare participation and diabetes care are target areas of work for each of the communities

36 Building a Bridge at the Quality Chasm
AHRQ’s Role The Quality Chasm Getting There from Here Q&A

37 Future Challenges Downstream effects of policy applications
Using technology, but not letting technology determine our priorities Care coordination: what can we learn from large integrated systems? Public-private funding and participation likely a necessity Patients should always be engaged as partners: it’s about them, not about you

38 What Does It Mean to Be ‘Patient-Centric?’

39 Technology and Consumers
We create tools that make care more efficient for clinicians Consumers already are comfortable with the technology; they’re leading us, not the other way around Consumers are demanding tools to make their care more about them; let’s satisfy the demand!

40 21st Century Health Care Using Information to Drive Improvement: Scientific Infrastructure to Support Reform Information-rich, patient-focused enterprises Information and evidence transform interactions from reactive to proactive (benefits and harms) Evidence is continually refined as a by-product of care delivery 21st Century Health Care Actionable information available – to clinicians AND patients – “just in time”

41 According to Yogi Berra
“If you don't know where you are going, you might wind up someplace else.” Yogi Berra

42 Funding Opportunities
Opportunities for the field to become involved are made available as soon as possible: To sign up for updates, visit To review AHRQ’s standing program and training award announcements

43 Building a Bridge at the Quality Chasm
AHRQ’s Role The Quality Chasm Getting There from Here Q&A


Download ppt "Agency for Healthcare Research and Quality"

Similar presentations


Ads by Google